Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: The All-new Robotic Visualization System KINEVO 900 from ZEISS Revolutionizes Neurosurgical Visualization
DGAP-News: Carl Zeiss Meditec AG / Key word(s): Product Launch
JENA/Germany, OBERKOCHEN/Germany, 25/04/2017. At this year’s Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) in Los Angeles the Medical Technology Business Group of ZEISS introduces KINEVO 900 – the first Robotic Visualization System. It combines Digital Hybrid Visualization – the possibility to use new digital or classical optical modes, QEVO – the unique Micro-Inspection Tool, and all-new Surgeon-Controlled Robotics. The three-in-one visualization solution merges the previously always separate functions of a surgical microscope, ocular-free digital 4K 3D exoscope and in-situ images to gain greater certainty, while using robotics to reduce manual effort in a unique, new way.
When working on a tumor case, neurosurgeons may need to return to identified regions of concern where they have to protect the functional structure. After storing these Bookmarks in PositionMemory, they can recall and return to the stored location at the exact same magnification, working distance and focus – without losing time for manual repositioning. Expanding the line of sight “I was fortunate enough to have the ability to use the QEVO addition to the microscope which I find really provides that final solution of being able to see around corners. It visualizes the area we are interested in, that we can’t see through the microscope. Because QEVO can be seen as it’s inserted into the operative field while still having the microscope view it adds a degree of safety that we have not had,” states Dr. Robert F. Spetzler, Barrow Neurological Institute, Phoenix, USA. To support the surgical workflow, QEVO is engineered with an angled design supporting safer insertion and keeping the hands out of the line of sight. This also makes it fit easily between KINEVO 900 and the situs, eliminating the need to reposition the microscope. In the development of the Micro-Inspection Tool, ZEISS placed a high priority on its ease of use: QEVO is truly integrated and available without planning – as it is fully autoclavable and there is no need for additional draping. Enabling ocular-free surgery Assistant surgeons, OR staff and residents also benefit from the 4K visual clarity of KINEVO 900. They share the same high-resolution, digital image allowing them to follow the procedure with comparable fidelity, delivering indispensable education and training. “Together with leading neurosurgeons we developed and integrated scores of cutting-edge innovations into ZEISS KINEVO 900,” says Dirk L. Brunner, Senior Vice President, Microsurgery Division, Medical Technology Business Group, “all with the goal of providing neurosurgeons with innovations that support them in their clinical decisions. We are convinced that our new Robotic Visualization SystemTM will help move the field to a new level.” Reference:
Contact for press Contact for investors Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on TecDAX of the German stock exchange, is one of the world’s leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases, including implants and consumable materials. The Company creates innovative visualization solutions in the field of microsurgery. With approximately 2,900 employees worldwide, the Group generated revenue of EUR 1,088 million in financial year 2015/16 (to 30 September). The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world’s leading companies in the optical and optoelectronic industries. For more information visit our website at: www.zeiss.com/med
25.04.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Carl Zeiss Meditec AG |
Göschwitzer Str. 51-52 | |
07745 Jena | |
Germany | |
Phone: | +49 (0)3641 220-0 |
Fax: | +49 (0)3641 220-112 |
E-mail: | investors.meditec@zeiss.com |
Internet: | www.meditec.zeiss.de |
ISIN: | DE0005313704 |
WKN: | 531370 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |